Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pingfu Fu

Showing results (211-220 of 268) with videos related to

Pageof 27
Sort By:
Leukemia & Lymphoma|January 19, 2021
Efficacy and cost-benefit of filgrastim administered after early assessment bone marrow biopsy during induction therapy for acute myeloid leukemiaJiasheng Wang, Marcos de Lima, Brenda W Cooper, et al.
American Journal of Hematology|April 21, 2020
Aggressive lymphoma subtype is a risk factor for venous thrombosis. Development of lymphoma - specific venous thrombosis prediction modelsGouri Dharmavaram, Shufen Cao, Suchitra Sundaram, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2022
Novel Radiomic Measurements of Tumor-Associated Vasculature Morphology on Clinical Imaging as a Biomarker of Treatment Response in Multiple CancersNathaniel Braman, Prateek Prasanna, Kaustav Bera, et al.
Science Advances|June 1, 2022
Spatial interplay patterns of cancer nuclei and tumor-infiltrating lymphocytes (TILs) predict clinical benefit for immune checkpoint inhibitorsXiangxue Wang, Cristian Barrera, Kaustav Bera, et al.
Molecular Cancer Therapeutics|August 15, 2014
Synergistic simvastatin and metformin combination chemotherapy for osseous metastatic castration-resistant prostate cancerMelissa A Babcook, Sanjeev Shukla, Pingfu Fu, et al.
Plos One|May 26, 2010
HPV infection and EGFR activation/alteration in HIV-infected East African patients with conjunctival carcinomaJing Jie Yu, Pingfu Fu, John J Pink, et al.
Plos One|September 1, 2018
Identifying the morphologic basis for radiomic features in distinguishing different Gleason grades of prostate cancer on MRI: Preliminary findingsGregory Penzias, Asha Singanamalli, Robin Elliott, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 26, 2006
Direct comparison of umbilical cord blood versus bone marrow-derived endothelial precursor cells in mediating neovascularization in response to vascular ischemiaMarcie R Finney, Nicholas J Greco, Stephen E Haynesworth, et al.
European Journal of Radiology Open|July 3, 2023
Novel radiomic analysis on bi-parametric MRI for characterizing differences between MR non-visible and visible clinically significant prostate cancerLin Li, Rakesh Shiradkar, Sree Harsha Tirumani, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 19, 2015
Comparison of 2 Carmustine-Containing Regimens in the Rituximab Era: Excellent Outcomes Even in Poor-Risk PatientsPaolo F Caimi, Basem M William, Carlos H Silva Rondon, et al.
Pageof 27

Showing results (211-220 of 268) with videos related to

Sort By:
Pageof 27
Leukemia & Lymphoma|January 19, 2021
Efficacy and cost-benefit of filgrastim administered after early assessment bone marrow biopsy during induction therapy for acute myeloid leukemiaJiasheng Wang, Marcos de Lima, Brenda W Cooper, et al.
American Journal of Hematology|April 21, 2020
Aggressive lymphoma subtype is a risk factor for venous thrombosis. Development of lymphoma - specific venous thrombosis prediction modelsGouri Dharmavaram, Shufen Cao, Suchitra Sundaram, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2022
Novel Radiomic Measurements of Tumor-Associated Vasculature Morphology on Clinical Imaging as a Biomarker of Treatment Response in Multiple CancersNathaniel Braman, Prateek Prasanna, Kaustav Bera, et al.
Science Advances|June 1, 2022
Spatial interplay patterns of cancer nuclei and tumor-infiltrating lymphocytes (TILs) predict clinical benefit for immune checkpoint inhibitorsXiangxue Wang, Cristian Barrera, Kaustav Bera, et al.
Molecular Cancer Therapeutics|August 15, 2014
Synergistic simvastatin and metformin combination chemotherapy for osseous metastatic castration-resistant prostate cancerMelissa A Babcook, Sanjeev Shukla, Pingfu Fu, et al.
Plos One|May 26, 2010
HPV infection and EGFR activation/alteration in HIV-infected East African patients with conjunctival carcinomaJing Jie Yu, Pingfu Fu, John J Pink, et al.
Plos One|September 1, 2018
Identifying the morphologic basis for radiomic features in distinguishing different Gleason grades of prostate cancer on MRI: Preliminary findingsGregory Penzias, Asha Singanamalli, Robin Elliott, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 26, 2006
Direct comparison of umbilical cord blood versus bone marrow-derived endothelial precursor cells in mediating neovascularization in response to vascular ischemiaMarcie R Finney, Nicholas J Greco, Stephen E Haynesworth, et al.
European Journal of Radiology Open|July 3, 2023
Novel radiomic analysis on bi-parametric MRI for characterizing differences between MR non-visible and visible clinically significant prostate cancerLin Li, Rakesh Shiradkar, Sree Harsha Tirumani, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 19, 2015
Comparison of 2 Carmustine-Containing Regimens in the Rituximab Era: Excellent Outcomes Even in Poor-Risk PatientsPaolo F Caimi, Basem M William, Carlos H Silva Rondon, et al.
Pageof 27